Parallax Volatility Advisers, L.P. Kala Pharmaceuticals, Inc. Transaction History

Parallax Volatility Advisers, L.P.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 15, 2019	SELL	$5.19 - $8.97 $57,609 - $99,567	-11,100 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$4.29 - $9.94 $47,619 - $110,334	11,100 New	11,100 $54,000
Q1 2018 May 15, 2018	SELL	$12.26 - $18.98 $14,932 - $23,117	-1,218 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$13.68 - $23.17 $16,662 - $28,221	1,218	1,218 $23,000

Ticker KALA
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,464,160
Market Cap $9.81M
Description
Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies using its proprietary mucus penetrating particles technology for the treatment of eye diseases. The company's product candidates include KPI-012, which is in clinical development stage for the treatment of persistent...

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.